Abeona TherapeuticsvsAbbott Laboratories

ABEO and ABT stock compared: price, dividend, valuation and results, from SEC filings.

ABEO

Abeona Therapeutics Inc.

$2.42

Value $138M

-1.22%
ABEO's page

ABT

Abbott Laboratories

$103.00

Value $179B

-0.84%
ABT's page

Abeona Therapeutics (ABEO) has a market value of $138M and Abbott Laboratories (ABT) $179B. Over the last year, with dividends, ABEO moved -42.4% and ABT -16.3%. Dividend yield: ABEO none, ABT 2.45%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABEO$138M

    ABT$179B

    ABT is 1,296 times ABEO

  • Revenue, 12 months

    ABEO$39M

    ABT$48.2B

    ABT is 1,236 times ABEO

  • Net income, 12 months

    ABEO-$63M

    ABT$4.7B

  • Operating margin

    ABEO-186.1%

    ABT13.8%

    199.9 points apart

  • ROIC

    ABEO-34.7%

    ABT6.3%

    41.0 points apart

  • P/E

    ABEO–

    ABT38.1

  • Dividend yield

    ABEO0.0%

    ABT2.5%

    2.5 points apart

  • 5-year return

    ABEO-86.9%

    ABT-10.3%

    76.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABEO-86.9%

ABT-10.3%

5010020222023202420252026
Returns by period
PeriodABEOWith dividendsABTWith dividends
1 year since November 19, 2025-42.4%Price -42.4%-16.3%Price -18.4%
3 years since November 20, 2023-42.7%-16.9% a yearPrice -42.7%+8.4%+2.7% a yearPrice +1.8%
5 years since November 19, 2021-86.9%-33.4% a yearPrice -86.9%-10.3%-2.1% a yearPrice -18.8%
10 years since November 22, 2016-98.6%-34.8% a yearPrice -98.6%+226.2%+12.5% a yearPrice +170.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABEOAbeona TherapeuticsABTAbbott Laboratories

Valuation

ABEOABT
Valuation
Price$2.42$103.00
Market value$138M$179B
Enterprise value (EV)–$206B
P/E–38.1
P/E, 5-year median–33.7
P/B1.13.5
EV/EBIT–31.0
Free cash flow yield–3.8%

Results and growth

ABEOABT
Results and growth
Revenue, 12 months$39M$48.2B
Net income, 12 months-$63M$4.7B
Free cash flow, 12 months-$66M$6.8B
Earnings per share, 12 months-$1.07$2.69
Revenue growth, year on year29.0%5.7%
Revenue growth a year, past-10.3%over 5 years+5.1%over 5 years
EPS growth a year, past–+8.3%over 5 years

Margins and returns on capital

ABEOABT
Margins and returns on capital
Gross margin65.1%56.9%
Operating margin-186.1%13.8%
Net margin-160.3%9.8%
ROIC-34.7%6.3%
ROE-42.9%9.1%

Balance sheet

ABEOABT
Balance sheet
Cash$135M$4.3B
Total debt–$31.2B
Net debt / EBITDA–3.3
Interest cover-24.5×6.7×

Dividends and buybacks

ABEOABT
Dividends and buybacks
Dividend yield–2.5%
Dividend per share, 12 months–$2.52
Dividend growth a year, past–+10.4%over 5 years
Buyback yield–0.5%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABEO or ABT

Didn't find what you were looking for?

Ask us
Which is bigger, Abeona Therapeutics or Abbott Laboratories?

By market value, Abbott Laboratories ($179B) is about 1,296.4 times Abeona Therapeutics ($138M), at today's prices.

How did ABEO and ABT stock do over the last 10 years?

Since November 22, 2016, ABEO's price moved -98.6% and ABT's +170.3%. With dividends: ABEO -98.6% (-34.8% a year), ABT +226.2% (+12.5% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABEO or ABT?

The dividend yield at today's price is none for Abeona Therapeutics and 2.45% for Abbott Laboratories. Over the last twelve months they paid – and $2.52 per share.

Which has the higher profit margins, Abeona Therapeutics or Abbott Laboratories?

Over the last twelve months, the net margin was -160.3% for Abeona Therapeutics and 9.8% for Abbott Laboratories, and the operating margin -186.1% and 13.8%. Revenue was $39M and $48.2B.

Which is the better investment, Abeona Therapeutics or Abbott Laboratories?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.